Testosterone Cypionate Injection Recalled for Incorrect Excipient Labeling
Pharm D Solutions is recalling Testosterone Cypionate 200 mg/mL vials because the label incorrectly lists grapeseed oil instead of sesame oil.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is unlikely to cause adverse health consequences. The issue is a minor labeling error regarding the excipient description.
Plain-English summary
Pharm D Solutions, LLC is recalling Testosterone Cypionate 200 mg/mL in Sesame Oil, 4 mL and 5 mL vials. The recall was initiated because the product description section of the label incorrectly states "in grapeseed oil" instead of "in sesame oil." The primary panel of the label is correct.
The affected product is prescription-only and intended for intramuscular injection. The specific lot involved is 09122016:34, with an expiration date of 09/07/2017. The recall covers 510 vials of the 4 mL size and 486 vials of the 5 mL size.
The product was distributed in Arizona and Washington. Consumers and healthcare providers should check their inventory for this specific lot number and stop using the product if it matches the description. They should contact Pharm D Solutions for further instructions or a refund.
The recalled product
- Product
- Testosterone Cypionate 200 mg/mL in Sesame Oil, 4 mL and 5 mL vials, Rx only, For IM injection, Pharm D Solutions, Loop West Houston, TX --- NDA 69699-1709-04
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable Steroid
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 09122016:34
- exp 09/07/2017
Distribution
Part of a larger recall action
This product is one of 2 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SeverePharm D Solutions Recalls Testosterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- CriticalStrohecker's Pharmacy Recalls Testosterone Cypionate Vials Due to Incorrect Formulation
FDA (Drugs) · 2015-06-03
- Severe
- SeverePharm D Solutions Recalls Testosterone Cypionate/Proprinate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereEssential Wellness Pharma Recalls Testosterone Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2015-11-25